MBX Biosciences, Inc. Common Stock

MBX Biosciences, Inc. Common Stock

MBX
MBX Biosciences, Inc. Common StockUS flagNASDAQ Global Select
60.28
USD
+0.14
- -
2.02BMarket Cap

Income Statement (USD)

APIChatGPT
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- Operating Expenses
25
35
68
98
+ Selling, General & Admin
4
7
11
19
+ Research & Development
21
29
57
79
+ Other Operating Expense
- -
- -
- -
- -
Operating Income (Loss)
-25
-35
-68
-98
- Non-Operating (Income) Loss
1
-3
-6
-11
+ Interest Expense, Net
- -
-3
-6
-11
+ Interest Expense
- -
- -
- -
- -
- Interest Income
- -
3
6
11
+ Other Non-Op (Income) Loss
1
- -
- -
- -
Pretax Income
-26
-33
-62
-87
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
Income (Loss) from Cont Ops
-26
-33
-62
-87
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
Income (Loss) Incl. MI
-26
-33
-62
-87
- Minority Interest
- -
- -
- -
- -
Net Income, GAAP
-26
-33
-62
-87
- Preferred Dividends
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-26
-33
-62
-87
EBIT
-25
-35
-68
-98
EBITDA
-25
-35
-68
-98
EBITDA Margin (%)
- -
- -
- -
- -
EBITA
-25
-35
-68
-98
Gross Margin (%)
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
Basic Weighted Avg Shares
32
32
11
37
Basic EPS, GAAP
-0.82
-1.02
-5.82
-2.38
Basic EPS from Cont Ops
-0.82
-1.02
-5.82
-2.38
Diluted Weighted Avg Shares
32
32
11
37
Diluted EPS, GAAP
-0.82
-1.02
-5.82
-2.38
Diluted EPS from Cont Ops
-0.82
-1.02
-5.82
-2.38

Balance Sheet (USD)

APIChatGPT
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
44
83
267
382
+ Cash, Cash Equivalents & STI
42
81
262
374
+ Cash & Cash Equivalents
24
31
49
75
+ ST Investments
18
50
213
298
+ Accounts & Notes Receiv
- -
- -
1
2
+ Accounts Receivable, Net
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
1
2
+ Inventories
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
+ Other ST Assets
2
3
4
6
+ Misc ST Assets
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
Total Noncurrent Assets
1
1
1
4
+ Property, Plant & Equip, Net
1
1
1
3
+ Property, Plant & Equip
1
1
2
4
- Accumulated Depreciation
- -
- -
- -
1
+ LT Investments & Receivables
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
+ Total Intangible Assets
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
Total Assets
45
84
269
385
+ Payables & Accruals
2
2
9
11
+ Accounts Payable
1
1
5
3
+ Accrued Taxes
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
+ Other Payables & Accruals
1
1
3
8
+ ST Debt
- -
- -
- -
- -
+ ST Borrowings
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
+ Other ST Liabilities
1
1
2
4
+ Deferred Revenue
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Misc ST Liabilities
1
1
2
4
Total Current Liabilities
3
4
11
15
+ LT Debt
- -
- -
- -
- -
+ LT Borrowings
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
+ Other LT Liabilities
84
153
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
+ Misc LT Liabilities
84
153
- -
- -
Total Noncurrent Liabilities
84
153
- -
- -
Total Liabilities
88
157
11
16
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
+ Share Capital & APIC
- -
3
395
593
+ Common Stock
- -
- -
- -
- -
+ Additional Paid in Capital
- -
3
395
593
- Treasury Stock
- -
- -
- -
- -
+ Retained Earnings
-43
-76
-138
-224
+ Other Equity
- -
- -
- -
- -
Equity Before Minority Interest
-43
-72
257
369
+ Minority/Non Controlling Interest
- -
- -
- -
- -
Total Equity
-43
-72
257
369
Total Liabilities & Equity
45
84
269
385
Shares Outstanding
32
32
33
45
Number of Employees
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
1
Net Debt
-24
-31
-49
-75
Net Debt to Equity
56.82
42.12
-19.17
-20.39
Tangible Common Equity Ratio
-94.48
-86.09
95.87
95.87
Current Ratio
12.89
21.26
24.19
24.62
Cash Conversion Cycle
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-26
-33
-62
-87
+ Depreciation & Amortization
- -
- -
- -
- -
+ Non-Cash Items
2
1
2
5
+ Stock-Based Compensation
- -
2
5
9
+ Deferred Income Taxes
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
+ Other Non-Cash Adj
1
-1
-3
-3
+ Chg in Non-Cash Work Cap
1
-1
5
2
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
-1
-1
-2
-3
+ Inc (Dec) in Accts Payable
2
- -
7
4
+ Inc (Dec) in Other
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Operating Activities
-23
-32
-55
-80
+ Change in Fixed & Intang
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
-1
-2
+ Acq of Fixed Prod Assets
- -
- -
-1
-2
+ Acq of Intangible Assets
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
175
188
+ Increase in Capital Stock
- -
- -
175
188
+ Decrease in Capital Stock
- -
- -
- -
- -
+ Net Change in LT Investment
-11
-31
-160
-82
+ Dec in LT Investment
9
33
80
276
+ Inc in LT Investment
-20
-64
-239
-358
+ Net Cash From Acq & Div
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Investing Activities
-11
-31
-161
-84
+ Dividends Paid
- -
- -
- -
- -
+ Net Cash From Debt
10
- -
- -
- -
+ Cash From Debt
10
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
+ Other Financing Activities
36
69
60
2
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Financing Activities
46
69
234
190
Effect of Foreign Exchange Rates
- -
- -
- -
- -
Net Changes in Cash
12
6
19
26
EBITDA
-25
-35
-68
-98
EBITDA Margin (%)
- -
- -
- -
- -
Free Cash Flow
-24
-32
-56
-82
Net Cash Paid for Acquisitions
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-32
-56
-82
Free Cash Flow per Basic Share
-0.74
-1.01
-5.22
-2.24
Price/Free Cash Flow
- -
- -
-3.65
-14.76
Cash Flow to Net Income
0.88
0.98
0.88
0.92
Capital Expenditures
- -
- -
-1
-2